Rahul Banerjee, MD
Clinical Instructor Volunteer
Medicine
School of Medicine
Awards
Show all (6) Hide
- Chief Fellow, Division of Hematology/Oncology, University of California San Francisco, 2019-2020
- ASTCT Clinical Research Training Course (Park City, UT), American Society for Transplantation and Cellular Therapy, 2019
- ASCO/AACR Methods in Clinical Cancer Research Workshop (Vail, CO), American Society of Clinical Oncology, 2019
- Alpha Omega Alpha Honor Medical Society, Warren Alpert Medical School (Brown University), 2014
- Gold Humanism Honor Society, Warren Alpert Medical School (Brown University), 2014
- Electee, Fellow of the American College of Physicians (FACP), American College of Physicians
Education & Training
Show all (5) Hide
- Advanced Fellowship BMT/CAR-T Therapy UCSF 06/2022
- Fellowship Hematology & Oncology UCSF 06/2021
- Chief Residency Quality Improvement Philadelphia VA Medical Center 06/2018
- Residency Internal Medicine Hospital of the University of Pennsylvania 06/2017
- MD (Medical School) Alpert Medical School of Brown University 05/2014
Websites
Show all (1) Hide
- @@RahulBanerjeeMD on Twitter (twitter.com)
Grants and Projects
Show all (1) Hide
- Efficacy of digital life coaching to lower benzodiazepine usage and improve quality of life in multiple myeloma patients undergoing transplantation, ASCO Conquer Cancer Foundation, 2020-2021
Publications (68)
Top publication keywords:
NitroimidazolesBortezomibHematologic NeoplasmsAgammaglobulinemiaPhysiciansScholarly CommunicationSocieties, NursingTransplantation, AutologousMultiple MyelomaFellowships and ScholarshipsHematologyDexamethasoneHematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveCongresses as Topic
-
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.
Blood cancer journal 2024 Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD, Cowan AJ, Rajkumar SV, Kaur G -
Salvage Therapies including Retreatment with BCMA-directed Approaches Following BCMA CAR-T Relapses for Multiple Myeloma.
Blood advances 2024 Reyes KR, Liu YC, Huang CY, Banerjee R, Martin T, Wong SW, Wolf JL, Arora S, Shah N, Chari A, Chung A -
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic.
Blood advances 2024 Banerjee R, Poh C, Hirayama AV, Gauthier J, Cassaday RD, Shadman M, Cowan AJ, Till BG, Green DJ, Kiem HP, Gopal AK, Maloney DG -
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.
Clinical lymphoma, myeloma & leukemia 2024 Banerjee R, Cowan AJ, Ortega M, Missimer C, Carpenter PA, Oshima MU, Salit RB, Vo PT, Lee CJ, Mehta RS, Kuderer NM, Shankaran V, Lee SJ, Su CT -
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
British journal of haematology 2023 Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B
Show all (63 more) Hide
-
Opportunity Strikes for Reducing Cancer Drug Waste: Bortezomib as an Example of Vial Mis-Sizing in Oncology.
JCO oncology practice 2023 Abrams HR, Chen AW, Banerjee R -
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.
Blood cancer journal 2023 Banerjee R, Wang B, Anderson LD, McCaughan G, Mehra N, Cowan AJ, Rajkumar SV, Kaur G -
Association between dexamethasone exposure and visually significant cataracts in multiple myeloma.
American journal of hematology 2023 Banerjee R, Hurtado Martínez JA, Flores Pérez PA, Porras N, Hydren J, Ahlstrom JM, Taravati P, Cowan AJ -
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling.
Frontiers in oncology 2023 Banerjee R, Cicero KI, Lee SS, Cowan AJ -
Randomized phase 2 study of digital life coaching during transplantation for myeloma.
Bone marrow transplantation 2023 Banerjee R, Huang CY, Ryan C, Lee A, Brassil KJ, Moore J, Arora S, Chung A, Wong SW, Wolf J, Martin T, Dhruva A, Shah N -
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Blood advances 2023 Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, … -
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
European journal of nuclear medicine and molecular imaging 2023 Banerjee R, Wang V, Huang CY, Pandita D, Leonard MK, LaRue S, Ahmadi M, Kaplan L, Ai WZ, Fakhri B, Spinner M, Seshadri MR, Pampaloni MH, Andreadis CB -
Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma.
Blood cancer journal 2023 Banerjee R, Williams L, Mikhael JR -
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma.
Transplantation and cellular therapy 2023 Zafar A, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Martin TG, Shah N, Banerjee R -
Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma.
Leukemia & lymphoma 2023 Natsuhara KH, Huang CY, Knoche J, Arora S, Chung A, Martin T, Wolf J, Wong SW, Shah N, Banerjee R -
Professional Challenges for United States Hematology/Oncology Trainees during COVID-19.
Cancer investigation 2023 Banerjee R, Kareff SA, Leyfman Y, Dhawan N, Hammons LR, Desai A, Tsang M, Velazquez AI, Nizam A -
Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships.
Transplantation and cellular therapy 2023 Banerjee R, Kelkar AH, Durani U, Anagnostou T, Nishitani M, Mallhi K, Majhail NS, Logan AC -
Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.
Transplantation and cellular therapy 2023 Reyes KR, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Olin RL, Martin T, Shah N, Banerjee R -
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.
British journal of haematology 2023 Ge AY, Huang CY, Banerjee R, Knoche J, Chung A, Arora S, Martin TG, Wolf J, Wong SW, Wiita AP, Shah N -
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Wang Y, Jain P, Locke FL, Maurer MJ, Frank MJ, Munoz JL, Dahiya S, Beitinjaneh AM, Jacobs MT, Mcguirk JP, Vose JM, Goy A, Andreadis C, Hill BT, Dorritie KA, Oluwole OO, Deol A, Paludo J, Shah B, Wang … -
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2023 Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT -
Clinical Validation of a Continuous Monitoring Mobile Cardiac Detection Device for Atrial Fibrillation.
The American journal of cardiology 2022 Banerjee S, Das T, Grodin J, Minniefield N, Tsai S, Banerjee R, Persen K, Novak S -
Innovation in BCMA CAR-T therapy: Building beyond the Model T.
Frontiers in oncology 2022 Banerjee R, Lee SS, Cowan AJ -
Myeloma, melphalan, and the taste of transplantation.
Cancer 2022 Banerjee R -
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma.
Blood advances 2022 Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee C, Mian H, Nathan S, Savani B, Kumar S, … -
SNPs and PROs in myeloma: the most ambitious crossover of all time?
Bone marrow transplantation 2022 Banerjee R, Shah N -
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report.
EJHaem 2022 Goyal V, Salmasi G, Leavitt AD, Rubenstein JL, Banerjee R -
Severe electrolyte derangements from lysozymuria in acute myeloid leukemia.
EJHaem 2022 Pérez-Pinzón J, Olin RL, Banerjee R -
Financial toxicity in hematological malignancies: a systematic review.
Blood cancer journal 2022 Ouchveridze E, Banerjee R, Desai A, Aziz M, Lee-Smith W, Mian H, Berger K, McClune B, Sborov D, Qazilbash M, Kumar S, Mohyuddin GR -
Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study.
JMIR formative research 2022 Banerjee R, Huang CY, Dunn L, Knoche J, Ryan C, Brassil K, Jackson L, Patel D, Lo M, Arora S, Wong SW, Wolf J, Martin Iii T, Dhruva A, Shah N -
Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022 Vo K, Guan T, Banerjee R, Lo M, Young R, Shah N -
Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2021 Banerjee R, Lo M, Klein L, Aras M, Logan AC -
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.
Bone marrow transplantation 2021 Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M,… -
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.
Transplantation and cellular therapy 2021 Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, … -
Synthetic control arms in studies of multiple myeloma and diffuse large B-cell lymphoma.
British journal of haematology 2021 Banerjee R, Midha S, Kelkar AH, Goodman A, Prasad V, Mohyuddin GR -
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.
Bone marrow transplantation 2021 Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S,… -
Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma.
Future oncology (London, England) 2021 Banerjee R, Lo M, Martin TG -
Lack of equipoise in the LIGHTHOUSE trial for patients with relapsed multiple myeloma: An ethical concern.
European journal of cancer (Oxford, England : 1990) 2021 Mohyuddin GR, Banerjee R, Goodman AM -
Rethinking mechanisms of neurotoxicity with BCMA directed therapy.
Critical reviews in oncology/hematology 2021 Mohyuddin GR, Banerjee R, Alam Z, Berger KE, Chakraborty R -
Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic Review.
JAMA network open 2021 Banerjee R, Prasad V -
Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome.
Leukemia & lymphoma 2021 Banerjee R, Fakhri B, Shah N -
Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health.
JCO clinical cancer informatics 2021 Banerjee R, Shah N, Dicker AP -
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond.
Current hematologic malignancy reports 2021 Banerjee R, Kelkar AH, Logan AC, Majhail NS, Pemmaraju N -
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma.
Transplantation and cellular therapy 2021 Banerjee R, Marsal J, Huang CY, Lo M, Kambhampati S, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N -
Driving distances and loss to follow-up after hematopoietic cell transplantation.
EJHaem 2021 Banerjee R, Loren AW -
Maximizing Home Time for Persons With Cancer.
JCO oncology practice 2021 Banerjee R, George M, Gupta A -
When and How to Treat Relapsed Multiple Myeloma.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2021 Nathwani N, Bertamini L, Banerjee R, Gay F, Shah N, Krishnan A -
'Stat' workflow modifications to expedite care after needlestick injuries.
Occupational medicine (Oxford, England) 2021 Smith JL, Banerjee R, Linkin DR, Schwab EP, Saberi P, Lanzi M -
Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation.
EJHaem 2021 Banerjee R, Lazar AA, Dunn L, Knoche J, Lo M, Arora S, Wong SW, Wolf JL, Martin TG, Dhruva A, Shah N -
Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19.
Nature reviews. Clinical oncology 2021 Banerjee R, Prasad V -
Virtual Conferences: Optimizing Oncology Nurses' Experience.
Clinical journal of oncology nursing 2020 Brassil KJ, Banerjee R -
Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2020 Banerjee R, Yi JC, Majhail NS, Jim HSL, Uberti J, Whalen V, Loren AW, Syrjala KL -
Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations?
JAMA network open 2020 Banerjee R, Prasad V -
Profanities, Promises, and Hospices.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Banerjee R -
Post-discharge Emergency Department Visits: Good, Bad, or Ugly?
Journal of hospital medicine 2018 Banerjee R, Greysen SR -
Late effects of blood and marrow transplantation.
Haematologica 2017 Banerjee R, Luskin MR, Loren AW -
If You Book It, Will They Come? Attendance at Postdischarge Follow-Up Visits Scheduled by Inpatient Providers.
Journal of hospital medicine 2017 Banerjee R, Suarez A, Kier M, Honeywell S, Feng W, Mitra N, Grande D, Myers J -
Resilience Through Grieving Rounds.
Academic medicine : journal of the Association of American Medical Colleges 2017 Banerjee R -
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study.
British journal of haematology 2017 Mato AR, Timlin C, Ujjani C, Skarbnik A, Howlett C, Banerjee R, Nabhan C, Schuster SJ -
Illiteracy
The Pharos of Alpha Omega Alpha Honor Medical Society 2017 Banerjee R -
Coloring the Silence.
Academic medicine : journal of the Association of American Medical Colleges 2016 Banerjee R -
A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.
Current hematologic malignancy reports 2015 Luskin MR, Banerjee R, Del Percio S, Loren AW -
Occurrence and recall rates of fertility discussions with young breast cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Banerjee R, Tsiapali E -
Medical student awareness of and interest in clinical informatics.
Journal of the American Medical Informatics Association : JAMIA 2015 Banerjee R, George P, Priebe C, Alper E -
To comfort, always.
Journal of palliative medicine 2014 Banerjee R -
The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid.
Journal of virology 2013 Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, Atwood WJ -
Lyme neuroborreliosis presenting with alexithymia and suicide attempts.
The Journal of clinical psychiatry 2013 Banerjee R, Liu JJ, Minhas HM -
Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus.
Virus research 2010 Haley SA, O'Hara BA, Banerjee R, Atwood WJ